Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Replimune Group, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −1 vs. Q3 2021
- Shares held
- 38.8M
- +3.48M (+9.8%) vs. Q3 2021
- Total value
- $1.05B
- +$2.77M (+0.3%) vs. Q3 2021
- New holders
- 11
- 39 more added
- Sold out
- 12
- 30 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prudential Financial Inc | 0 | $0 | 0.00% | −19,240−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −9,232−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −8,167−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −7,329−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −7,131−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −4,093−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,794−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,202−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,070−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −485−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |